{
    "Trade/Device Name(s)": [
        "SYNCHRON\u00ae Systems Cholinesterase (CHEX) Reagent",
        "SYNCHRON Systems Cholinesterase (CHEX) assay"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K103373",
    "Predicate Device Reference 510(k) Number(s)": [
        "K030045"
    ],
    "Regulatory Class": "Class I Reserved",
    "Product Code(s)": [
        "DIH"
    ],
    "Summary Letter Date": "November 16, 2010",
    "Summary Letter Received Date": "November 17, 2010",
    "Submission Date": "November 16, 2010",
    "Regulation Number(s)": [
        "21 CFR 862.3240"
    ],
    "Regulation Name(s)": [
        "Cholinesterase test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cholinesterase"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium Heparin tube",
        "Sodium Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Beckman Coulter Synchron CX Pro System",
        "Synchron LX Pro System",
        "UniCel DxC 600/800 System"
    ],
    "Method(s)/Technology(ies)": [
        "Chromogenic color change measured by spectrophotometer"
    ],
    "Methodologies": [
        "Quantitative enzymatic activity assay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for SYNCHRON Systems Cholinesterase (CHEX) Reagent for measuring cholinesterase activity in serum and plasma on Beckman Coulter analyzers.",
    "Indications for Use Summary": "Quantitative determination of Cholinesterase activity in human serum and plasma, used in diagnosis and treatment of cholinesterase inhibition disorders such as insecticide and succinylcholine poisoning.",
    "fda_folder": "Toxicology"
}